Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Neuropharmacology

  • You have access
    The Effect of Central Angiotensin II Receptor Blockade on Interleukin-1β- and Prostaglandin E-Induced Fevers in Rats: Possible Involvement of Brain Angiotensin II Receptor in Fever Induction
    Tatsuo Watanabe, Yukio Saiki and Yoshiyuki Sakata
    Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 873-881;
  • You have access
    Activation of the Cloned Human Kappa Opioid Receptor by Agonists Enhances [35S]GTPγS Binding to Membranes: Determination of Potencies and Efficacies of Ligands
    Jinmin Zhu, Lai-Yi Luo, Jian-Guo Li, Chongguang Chen and Lee-Yuan Liu-Chen
    Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 676-684;
  • You have access
    I. NGD 94–1: Identification of a Novel, High-Affinity Antagonist at the Human Dopamine D4 Receptor
    John F. Tallman, Renee J. Primus, Robbin Brodbeck, Linda Cornfield, Robin Meade, Kristine Woodruff, Phillip Ross, Andrew Thurkauf and Dorothy W. Gallager
    Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 1011-1019;
  • You have access
    WIN 35,428 and Mazindol Are Mutually Exclusive in Binding to the Cloned Human Dopamine Transporter
    Cen Xu and Maarten E. A. Reith
    Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 920-927;
  • You have access
    The Kappa Opioid Agonist Niravoline Decreases Brain Edema in the Mouse Middle Cerebral Artery Occlusion Model of Stroke
    Claude Guéniau and Claude Oberlander
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 1-6;
  • You have access
    The Potassium Channel Blockers 4-Aminopyridine and Tetraethylammonium Increase the Spontaneous Basal Release of [3H]5-Hydroxytryptamine in Rat Hippocampal Slices
    Lee E. Schechter
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 262-270;
  • You have access
    Antagonism of N-Methyl-d-Aspartate Receptors by ς Site Ligands: Potency, Subtype-Selectivity and Mechanisms of Inhibition
    E. R. Whittemore, V. I. Ilyin and R. M. Woodward
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 326-338;
  • You have access
    Pharmacological Comparison of Transient and Persistent [3H]Dopamine Release from Mouse Striatal Synaptosomes and Response to Chronic l-Nicotine Treatment
    Sharon R. Grady, Elizabeth U. Grun, Michael J. Marks and Allan C. Collins
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 32-43;
  • You have access
    Pharmacology of Lobeline, A Nicotinic Receptor Ligand
    M. I. Damaj, G. S. Patrick, K. R. Creasy and B. R. Martin
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 410-419;
  • You have access
    N-(3-Iodoprop-2E-enyl)-2β-carbomethoxy-3β-(3′,4′-dichlorophenyl)nortropane (β-CDIT), a Tropane Derivative: Pharmacological Characterization as a Specific Ligand for the Dopamine Transporter in the Rodent Brain
    Lucette Garreau, Patrick Emond, Catherine Belzung, Denis Guilloteau, Yves Frangin, Jean-Claude Besnard and Sylvie Chalon
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 467-474;

Pages

  • Previous
  • Next
  • 1
  • …
  • 209
  • 210
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • …
  • 221
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics